Global Implanted Infusion Port Market Growth 2025-2031
Description
The global Implanted Infusion Port market size is predicted to grow from US$ 660 million in 2025 to US$ 938 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Implanted Infusion Port is a closed intravenous infusion system that can be completely implanted subcutaneously and remain in the body for a long time. It consists of an injection seat (also known as a port body) implanted subcutaneously and a venous catheter system, with the tip located in the superior vena cava, providing a reliable venous access for patients who need long-term infusion therapy, and can be used for drug infusion, fluid replacement, nutritional support therapy, blood transfusion, blood sample collection, etc.
United States market for Implanted Infusion Port is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Implanted Infusion Port is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Implanted Infusion Port is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Implanted Infusion Port players cover AngioDynamics, Teleflex, B Braun, Baxter, Bayer HealthCare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Implanted Infusion Port Industry Forecast” looks at past sales and reviews total world Implanted Infusion Port sales in 2024, providing a comprehensive analysis by region and market sector of projected Implanted Infusion Port sales for 2025 through 2031. With Implanted Infusion Port sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implanted Infusion Port industry.
This Insight Report provides a comprehensive analysis of the global Implanted Infusion Port landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implanted Infusion Port portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implanted Infusion Port market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implanted Infusion Port and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implanted Infusion Port.
This report presents a comprehensive overview, market shares, and growth opportunities of Implanted Infusion Port market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Chest Infusion Port
Upper Arm Infusion Port
Segmentation by Application:
Pain Management
Drug Delivery and Chemotherapy
Blood Exchange
Nutritional Support
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AngioDynamics
Teleflex
B Braun
Baxter
Bayer HealthCare
Becton Dickinson
ICU Medical
PEROUSE MEDICAL
Smiths Medical
Terumo
Medtronic
Mindray Medical
Moog Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Implanted Infusion Port market?
What factors are driving Implanted Infusion Port market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implanted Infusion Port market opportunities vary by end market size?
How does Implanted Infusion Port break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Implanted Infusion Port is a closed intravenous infusion system that can be completely implanted subcutaneously and remain in the body for a long time. It consists of an injection seat (also known as a port body) implanted subcutaneously and a venous catheter system, with the tip located in the superior vena cava, providing a reliable venous access for patients who need long-term infusion therapy, and can be used for drug infusion, fluid replacement, nutritional support therapy, blood transfusion, blood sample collection, etc.
United States market for Implanted Infusion Port is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Implanted Infusion Port is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Implanted Infusion Port is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Implanted Infusion Port players cover AngioDynamics, Teleflex, B Braun, Baxter, Bayer HealthCare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Implanted Infusion Port Industry Forecast” looks at past sales and reviews total world Implanted Infusion Port sales in 2024, providing a comprehensive analysis by region and market sector of projected Implanted Infusion Port sales for 2025 through 2031. With Implanted Infusion Port sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implanted Infusion Port industry.
This Insight Report provides a comprehensive analysis of the global Implanted Infusion Port landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implanted Infusion Port portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implanted Infusion Port market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implanted Infusion Port and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implanted Infusion Port.
This report presents a comprehensive overview, market shares, and growth opportunities of Implanted Infusion Port market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Chest Infusion Port
Upper Arm Infusion Port
Segmentation by Application:
Pain Management
Drug Delivery and Chemotherapy
Blood Exchange
Nutritional Support
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AngioDynamics
Teleflex
B Braun
Baxter
Bayer HealthCare
Becton Dickinson
ICU Medical
PEROUSE MEDICAL
Smiths Medical
Terumo
Medtronic
Mindray Medical
Moog Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Implanted Infusion Port market?
What factors are driving Implanted Infusion Port market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implanted Infusion Port market opportunities vary by end market size?
How does Implanted Infusion Port break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
123 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Implanted Infusion Port by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Implanted Infusion Port by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
